Sinclair Pharma

	Group		Company
	2008	2007	2008	2007
	£'000	£'000	£'000	£'000
Trade receivables	12,154	7,433	—	—
Less provision for impairment of trade receivables	(113)	(809)	—	—
Trade receivables – net	12,041	6,624	—	—
Amounts due from Group undertakings	—	—	—	7,768
Other receivables	1,144	400	—	—
Prepayments and accrued income	1,284	776	37	18
	14,469	7,800	37	7,786

Amounts due from Group undertakings have been reclassified to investments to reflect the long-term nature of these balances.

The ageing of trade receivables is as follows:

Receivables past due but not impaired relate to wholesalers and marketing partners for whom there is no recent history of default.

Movements on the Group’s provision for impairment of trade receivables are as follows:

	Group
	2008	2007
	£'000	£'000
At 1 July
Provision for receivables impairment	809	70
Receivables written off during the year as uncollectible	107	798
Unused amounts reversed	(803)	(59)
	113	809

The table below shows the top three debtors at 30 June 2008, and the comparative balance as at 30 June 2007.

The carrying amounts of the Group’s trade and other receivables are denominated in the following currencies:

Amounts owed by Group undertakings are interest free, unsecured and have no fixed date of repayment.

Sinclair Pharma Text-only version